263 related articles for article (PubMed ID: 28416981)
1. Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction.
Jimenez-Juan L; Karur GR; Connelly KA; Deva D; Yan RT; Wald RM; Singh S; Leung G; Oikonomou A; Dorian P; Angaran P; Yan AT
J Arrhythm; 2017 Apr; 33(2):134-138. PubMed ID: 28416981
[TBL] [Abstract][Full Text] [Related]
2. Right Ventricular Function at Cardiac MRI Predicts Cardiovascular Events in Patients with an Implantable Cardioverter-Defibrillator.
Jimenez-Juan L; Ben-Dov N; Goncalves Frazao CV; Tan NS; Singh SM; Dorian P; Angaran P; Oikonomou A; Kha LT; Roifman I; Chacko B; Connelly KA; Kirpalani A; Deva D; Yan AT
Radiology; 2021 Nov; 301(2):322-329. PubMed ID: 34402663
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator.
Urzua Fresno CM; Folador L; Shalmon T; Hamad FMD; Singh SM; Karur GR; Tan NS; Mangat I; Kirpalani A; Chacko BR; Jimenez-Juan L; Yan AT; Deva DP
J Cardiovasc Magn Reson; 2021 Jun; 23(1):72. PubMed ID: 34108003
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
[TBL] [Abstract][Full Text] [Related]
5. Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
Elming MB; Hammer-Hansen S; Voges I; Nyktari E; Raja AA; Svendsen JH; Pehrson S; Signorovitch J; Køber LV; Prasad SK; Thune JJ
Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007022. PubMed ID: 30866666
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
[TBL] [Abstract][Full Text] [Related]
7. Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy.
Al'Aref SJ; Altibi AM; Malkawi A; Mansour M; Baskaran L; Masri A; Rahmouni H; Abete R; Andreini D; Aquaro G; Barison A; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; Conte E; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Dobrovie M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Guglielmo M; Lanzillo C; Lombardi M; Lorenzoni V; Lozano-Torres J; Margonato D; Martini C; Marzo F; Masci P; Masi A; Memeo R; Moro C; Mushtaq S; Nese A; Palumbo A; Pavon AG; Pedrotti P; Pepi M; Perazzolo Marra M; Pica S; Pradella S; Presicci C; Rabbat MG; Raineri C; Rodriguez-Palomares JF; Sbarbati S; Schoepf UJ; Squeri A; Sverzellati N; Symons R; Tat E; Timpani M; Todiere G; Valentini A; Varga-Szemes A; Volpe A; Fusini L; Guaricci AI; Schwitter J; Pontone G
Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):472-482. PubMed ID: 35792682
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular geometry predicts ventricular tachyarrhythmia in patients with left ventricular systolic dysfunction: a comprehensive cardiovascular magnetic resonance study.
Nakamori S; Ismail H; Ngo LH; Manning WJ; Nezafat R
J Cardiovasc Magn Reson; 2017 Oct; 19(1):79. PubMed ID: 29058590
[TBL] [Abstract][Full Text] [Related]
9. Volumetric left ventricular ejection fraction is superior to 2-dimensional echocardiography for risk stratification of patients for primary prevention implantable cardioverter-defibrillator implantation.
Rayatzadeh H; Patel SJ; Hauser TH; Ngo LL; Shaw JL; Tan A; Buxton AE; Zimetbaum P; Josephson ME; Appelbaum E; Manning WJ; Nezafat R
Am J Cardiol; 2013 Apr; 111(8):1175-9. PubMed ID: 23375599
[TBL] [Abstract][Full Text] [Related]
10. Cardiac MRI and radionuclide ventriculography for measurement of left ventricular ejection fraction in ICD candidates.
Kotha VK; Deva DP; Connelly KA; Freeman MR; Yan RT; Mangat I; Kirpalani A; Barfett JJ; Sloninko J; Lin HM; Graham JJ; Crean AM; Jimenez-Juan L; Dorian P; Yan AT
Magn Reson Imaging; 2018 Oct; 52():69-74. PubMed ID: 29859946
[TBL] [Abstract][Full Text] [Related]
11. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
[TBL] [Abstract][Full Text] [Related]
12. Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death.
House CM; Nguyen D; Thomas AJ; Nelson WB; Zhu DW
J Card Fail; 2016 Feb; 22(2):125-32. PubMed ID: 26522819
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular ejection fraction as criterion for implantation of an implantable cardioverter-defibrillator in heart failure patients undergoing surgical left ventricular reconstruction.
Mollema SA; Klein P; Heersche J; Schalij MJ; Van der Wall EE; Versteegh MI; Klautz RJ; Van Erven L; Bax JJ
Pacing Clin Electrophysiol; 2009 Jul; 32(7):913-7. PubMed ID: 19572868
[TBL] [Abstract][Full Text] [Related]
14. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance outperforms echocardiography to predict subsequent implantable cardioverter defibrillator therapies in ST-segment elevation myocardial infarction patients.
Marcos-Garcés V; Perez N; Gavara J; Lopez-Lereu MP; Monmeneu JV; Rios-Navarro C; de Dios E; Merenciano-González H; Gabaldon-Pérez A; Ferrero-De-Loma-Osorio Á; Martínez-Brotons Á; Bondanza L; Sánchez-Gómez JM; Albiach C; Nunez J; Bayés-Genís A; Chorro FJ; Ruiz-Granell R; Bodi V
Front Cardiovasc Med; 2023; 10():991307. PubMed ID: 36818338
[TBL] [Abstract][Full Text] [Related]
16. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.
Papanastasiou CA; Bazmpani MA; Kokkinidis DG; Zegkos T; Efthimiadis G; Tsapas A; Karvounis H; Ziakas A; Kalogeropoulos AP; Kramer CM; Karamitsos TD
Int J Cardiol; 2022 Dec; 368():94-103. PubMed ID: 35961612
[TBL] [Abstract][Full Text] [Related]
18. Can 3D RVEF be Prognostic for the Non-Ischemic Cardiomyopathy Patient but not the Ischemic Cardiomyopathy Patient? A Cardiovascular MRI Study.
Gill SS; Doyle M; Thompson DV; Williams R; Yamrozik J; Grant SB; Biederman RWW
Diagnostics (Basel); 2019 Jan; 9(1):. PubMed ID: 30678130
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility.
Schiau C; Leucuța DC; Dudea SM; Manole S
Biology (Basel); 2021 Oct; 10(11):. PubMed ID: 34827101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
